Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 2
2009 8
2010 7
2012 1
2013 4
2014 5
2015 4
2016 4
2017 6
2018 3
2019 2
2020 4
2021 4
2022 6
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Drugging p53 for non-cancer diseases.
Jiang F, Li CG, Seto SW. Jiang F, et al. Among authors: seto sw. Front Pharmacol. 2022 Nov 30;13:1101742. doi: 10.3389/fphar.2022.1101742. eCollection 2022. Front Pharmacol. 2022. PMID: 36532782 Free PMC article. No abstract available.
The role of p53 in the alternation of vascular functions.
Chan GH, Chan E, Kwok CT, Leung GP, Lee SM, Seto SW. Chan GH, et al. Among authors: seto sw. Front Pharmacol. 2022 Sep 6;13:981152. doi: 10.3389/fphar.2022.981152. eCollection 2022. Front Pharmacol. 2022. PMID: 36147350 Free PMC article. Review.
Crocins for Ischemic Stroke: A Review of Current Evidence.
Shahbaz K, Chang D, Zhou X, Low M, Seto SW, Li CG. Shahbaz K, et al. Among authors: seto sw. Front Pharmacol. 2022 Aug 5;13:825842. doi: 10.3389/fphar.2022.825842. eCollection 2022. Front Pharmacol. 2022. PMID: 35991882 Free PMC article. Review.
Structure-Activity Relationship Studies of 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine (FPMINT) Analogues as Inhibitors of Human Equilibrative Nucleoside Transporters.
Li R, Mak WW, Li J, Zheng C, Shiu PH, Seto SW, Lee SM, Leung GP. Li R, et al. Among authors: seto sw. Front Pharmacol. 2022 Feb 21;13:837555. doi: 10.3389/fphar.2022.837555. eCollection 2022. Front Pharmacol. 2022. PMID: 35264969 Free PMC article.
59 results